|
|
|
|
| LEADER |
01610nmm a2200385 u 4500 |
| 001 |
EB001902370 |
| 003 |
EBX01000000000000001065279 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
201006 ||| eng |
| 100 |
1 |
|
|a Hotez, Peter J.
|
| 245 |
0 |
0 |
|a The development of SARS-CoV-2 vaccines
|h Elektronische Ressource
|c Peter Hotez
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2020, 2020
|
| 300 |
|
|
|a 1 streaming audio file (09 min.))
|
| 505 |
0 |
|
|a Contents: Overview of three SARS-CoV-2 vaccines being developed -- Technologies being used -- Manufacturability -- Current stage of testing -- Next steps
|
| 653 |
|
|
|a Drug Development / methods
|
| 653 |
|
|
|a severe acute respiratory syndrome coronavirus 2
|
| 653 |
|
|
|a COVID-19 (Disease) / Prevention
|
| 653 |
|
|
|a Betacoronavirus / drug effects
|
| 653 |
|
|
|a COVID-19 vaccine
|
| 653 |
|
|
|a Coronavirus infections / Vaccination
|
| 653 |
|
|
|a Viral Vaccines / administration & dosage
|
| 653 |
|
|
|a SARS Virus / immunology
|
| 653 |
|
|
|a Vaccines / Development
|
| 653 |
|
|
|a Coronavirus Infections / immunology
|
| 653 |
|
|
|a Coronavirus Infections / prevention & control
|
| 653 |
|
|
|a Recombinant Proteins / immunology
|
| 653 |
|
|
|a Randomized Clinical Trials as Topic
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Research and clinical interviews
|
| 500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4324
|x Verlag
|z Streaming video file
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1060
|3 Series
|
| 082 |
0 |
|
|a 570
|